Hyperfine (HYPR) EBIT Margin Growth (3y) (2024 - 2026)
Hyperfine (HYPR) EBIT Margin Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 1,505.00 |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | -184.00 |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 2,016.00 |
| 10 | Hyperfine | 94.51 Mn | 53.23 Mn | 1.98 Mn | 27,542.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,542.00 |
| Dec 31, 2025 | 81,222.00 |
| Sep 30, 2025 | 30,614.00 |
| Jun 30, 2025 | 115,695.00 |
| Mar 31, 2025 | 106,513.00 |
| Dec 31, 2024 | 551,945.00 |
| Sep 30, 2024 | 411,686.00 |
| Jun 30, 2024 | 377,560.00 |
| Mar 31, 2024 | 203,479.00 |